• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾衰竭患者的生育状况:ANZDATA 登记处生育数据完整性的演变和评估。

Parenthood in people with kidney failure: evolution and evaluation of completeness of ANZDATA registry parenthood data.

机构信息

Central Northern Adelaide Renal and Transplantation Services (CNARTS), Royal Adelaide Hospital, Port Road, Adelaide, South Australia, 5000, Australia.

Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), South Australian Health & Medical Research Institute (SAHMRI), Adelaide, Australia.

出版信息

J Nephrol. 2023 Sep;36(7):2125-2131. doi: 10.1007/s40620-023-01696-8. Epub 2023 Aug 9.

DOI:10.1007/s40620-023-01696-8
PMID:37556051
Abstract

BACKGROUND

Parenthood data has been collected by the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) since its inception in 1968, with a specific parenthood survey since 2001 of core maternal and fetal outcomes, which was further expanded in 2017 to collect additional obstetric and clinical data. We evaluated the parenthood dataset completeness over the evolution of the surveys.

METHODS

Descriptive statistics were used to quantify the completeness of data reported for male and female patients receiving KRT between 1963 and 2021 and compare parenthood surveys over time.

RESULTS

Core data items consistently had more than 85% completeness rates for all survey iterations. Most data items introduced in 2018 had less than 85% completeness. Of these, drug therapy during pregnancy, common medical complications, and labour and delivery data items had the highest completeness (70-85%), whereas dialysis-related items had a wide range of completeness, ranging from 44 to 80%.

CONCLUSION

Our findings underpin the robustness of the ANZDATA parenthood dataset but also highlight that more detailed clinical data can be difficult to capture, despite enabling better understanding of drivers of outcomes and risk stratification in this high-risk cohort. To overcome current limitations, strategies must be implemented to augment data completeness.

摘要

背景

自 1968 年成立以来,澳大利亚和新西兰透析和移植登记处(ANZDATA)一直在收集育儿数据,自 2001 年以来,一直在进行核心母婴和胎儿结局的专门育儿调查,该调查在 2017 年进一步扩大,以收集额外的产科和临床数据。我们评估了随着调查的发展,育儿数据集的完整性。

方法

使用描述性统计来量化 1963 年至 2021 年间接受 KRT 的男性和女性患者报告数据的完整性,并比较随时间推移的育儿调查。

结果

核心数据项目在所有调查迭代中始终具有超过 85%的完整性率。2018 年引入的大多数数据项目的完整性都低于 85%。在这些项目中,妊娠期间的药物治疗、常见的医疗并发症以及分娩数据项目的完整性最高(70-85%),而与透析相关的项目的完整性范围很广,从 44%到 80%不等。

结论

我们的研究结果为 ANZDATA 育儿数据集的稳健性提供了依据,但也强调,尽管可以更好地了解高风险人群中结局和风险分层的驱动因素,但更详细的临床数据可能难以捕捉。为了克服当前的限制,必须实施策略来提高数据的完整性。

相似文献

1
Parenthood in people with kidney failure: evolution and evaluation of completeness of ANZDATA registry parenthood data.肾衰竭患者的生育状况:ANZDATA 登记处生育数据完整性的演变和评估。
J Nephrol. 2023 Sep;36(7):2125-2131. doi: 10.1007/s40620-023-01696-8. Epub 2023 Aug 9.
2
Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22 years.影响澳大利亚接受肾脏替代治疗的女性生育率的因素:22 年来澳大利亚和新西兰透析和移植登记处及围产期数据的分析。
Nephrol Dial Transplant. 2022 May 25;37(6):1152-1161. doi: 10.1093/ndt/gfab157.
3
The outcomes of patients with kidney failure due to focal segmental glomerulosclerosis (FSGS) in Australia and New Zealand: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).澳大利亚和新西兰局灶节段性肾小球硬化症(FSGS)导致肾衰竭患者的结局:一项使用澳大利亚和新西兰透析和移植登记处(ANZDATA)的队列研究。
PLoS One. 2023 Nov 2;18(11):e0293721. doi: 10.1371/journal.pone.0293721. eCollection 2023.
4
Parenthood and pregnancy in Australians receiving treatment for end-stage kidney disease: protocol of a national study of perinatal and parental outcomes through population record linkage.接受终末期肾病治疗的澳大利亚人的为人父母与妊娠情况:一项通过人口记录链接研究围产期和父母结局的全国性研究方案。
BMJ Open. 2020 May 25;10(5):e036329. doi: 10.1136/bmjopen-2019-036329.
5
Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting).注册数据的有效性:终末期肾病注册(自愿报告)中的癌症记录与癌症登记处(法定报告)之间的一致性。
Nephrology (Carlton). 2010 Jun;15(4):491-501. doi: 10.1111/j.1440-1797.2010.01297.x.
6
Characteristics and clinical outcomes of patients with kidney failure of unknown aetiology from ANZDATA registry.来自澳新透析和移植登记处病因不明的肾衰竭患者的特征和临床结局
PLoS One. 2024 Mar 11;19(3):e0300259. doi: 10.1371/journal.pone.0300259. eCollection 2024.
7
Data quality of the Australia and New Zealand Dialysis and Transplant Registry: a pilot audit.澳大利亚和新西兰透析和移植登记处的数据质量:试点审计。
Nephrology (Carlton). 2013 Oct;18(10):665-70. doi: 10.1111/nep.12126.
8
Evaluating data quality in the Australian and New Zealand dialysis and transplant registry using administrative hospital admission datasets and data-linkage.利用行政医院入院数据集和数据链接评估澳大利亚和新西兰透析和移植登记处的数据质量。
Health Inf Manag. 2023 Sep;52(3):212-220. doi: 10.1177/18333583221097724. Epub 2022 Jun 11.
9
ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.千禧年末澳大利亚和新西兰的终末期肾病:来自澳新透析与移植登记处的报告
Am J Kidney Dis. 2002 Dec;40(6):1122-31. doi: 10.1053/ajkd.2002.36943.
10
Comparison of cause of death between Australian and New Zealand Dialysis and Transplant Registry and the Australian National Death Index.澳大利亚和新西兰透析与移植登记处与澳大利亚国家死亡指数之间的死因比较。
Nephrology (Carlton). 2019 Mar;24(3):322-329. doi: 10.1111/nep.13250.

引用本文的文献

1
Significant kidney disease in pregnancy: Feasibility and outcomes of a national population-based study using the Australasian Maternity Outcomes Surveillance System.妊娠期严重肾脏疾病:利用澳大利亚和新西兰孕产妇结局监测系统开展全国性基于人群研究的可行性及结果
Aust N Z J Obstet Gynaecol. 2025 Apr;65(2):227-234. doi: 10.1111/ajo.13885. Epub 2024 Sep 27.

本文引用的文献

1
Determinants of Perinatal Outcomes in Dialyzed and Transplanted Women in Australia.澳大利亚透析和移植女性围产期结局的决定因素
Kidney Int Rep. 2022 Mar 23;7(6):1318-1331. doi: 10.1016/j.ekir.2022.03.015. eCollection 2022 Jun.
2
Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders.罕见病登记处数据采集以支持监管决策制定:行业和其他利益相关者的调查研究。
Drug Saf. 2021 Aug;44(8):853-861. doi: 10.1007/s40264-021-01081-z. Epub 2021 Jun 6.
3
Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22 years.
影响澳大利亚接受肾脏替代治疗的女性生育率的因素:22 年来澳大利亚和新西兰透析和移植登记处及围产期数据的分析。
Nephrol Dial Transplant. 2022 May 25;37(6):1152-1161. doi: 10.1093/ndt/gfab157.
4
Pregnancy outcomes for simultaneous Pancreas-Kidney transplant recipients versus kidney transplant recipients.同期胰肾联合移植受者与单纯肾移植受者的妊娠结局比较。
Clin Transplant. 2021 Jan;35(1):e14151. doi: 10.1111/ctr.14151. Epub 2020 Dec 6.
5
Fatherhood and Kidney Replacement Therapy: Analysis of the Australian and New Zealand Dialysis and Transplant (ANZDATA) Registry.父亲身份与肾脏替代治疗:澳大利亚和新西兰透析与移植(ANZDATA)登记处分析
Am J Kidney Dis. 2020 Sep;76(3):444-446. doi: 10.1053/j.ajkd.2020.03.020. Epub 2020 May 28.
6
Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD.终末期肾病(ESRD)女性患者妊娠结局与受孕前或受孕后开始透析的关系。
Clin J Am Soc Nephrol. 2014 Jan;9(1):143-9. doi: 10.2215/CJN.03560413. Epub 2013 Nov 14.